Life AI Net
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
Hot
ログイン
日本語
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ログイン
ホーム
アーカイブ
計算ツール
ディレクトリ
More
ライブ
FierceBiotech
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure
FierceBiotech
With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
Lonza News
FDA-backed drug project tests modeling to reduce some human studies - Stock Titan
Thermo Fisher
Saladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays - Clinical Lab Products
Thermo Fisher
TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance
Lonza News
Lonza Group AG stock (CH0013841017): Is its biopharma contract model resilient enough for new growth - AD HOC NEWS
FierceBiotech
Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
10x Genomics Blog
10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience
Illumina
Clinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com
Thermo Fisher
Assessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st
Curiosis Inc.
Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView
Waters
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill
FierceBiotech
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure
FierceBiotech
With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
Lonza News
FDA-backed drug project tests modeling to reduce some human studies - Stock Titan
Thermo Fisher
Saladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays - Clinical Lab Products
Thermo Fisher
TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance
Lonza News
Lonza Group AG stock (CH0013841017): Is its biopharma contract model resilient enough for new growth - AD HOC NEWS
FierceBiotech
Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
10x Genomics Blog
10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience
Illumina
Clinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com
Thermo Fisher
Assessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st
Curiosis Inc.
Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView
Waters
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill
アーカイブ
BioWorld
2026年3月26日
Other news to note for March 26, 2026
Other news to note for March 26, 2026
原文
本文は利用できません。元の情報源をご確認ください。